Decoding DHR's Earnings Beat Rate and Post-Report Drift
DHR has beaten earnings expectations in 7/8 (100%) of its last eight reported quarters, with an average earnings surprise of 7.3%. Over the most recent four quarters, the company reported actual EPS of $1.94 on 2026-07-21, $2.06 on 2026-04-21, $2.23 on 2026-01-28, and $1.89 on 2025-10-21, against respective estimates of $1.85, $1.94, $2.16, and $1.72. Those prints translate to surprises of 4.9%, 6.2%, 3.2%, and 9.9%, all of them beats.
Despite the beat record, the post-earnings price action has drifted lower. The average 5-day move in the five trading days after earnings across the last eight quarters is -3.99%, classified as a "down" drift. The three preceding reports all finished red over that window: the April 2026 release dropped 8%, the January 2026 release slipped 2.23%, and the October 2025 release fell 1.75%, while the July 2026 release recorded a null% five-day move. The next-day reactions have been negative in three of the last four: -1.21%, -2.19%, and -5.4%, with only the July 2026 report posting a +0.07% next-day gain. For DHR, a headline beat has not translated into sustained buying pressure within this eight-quarter window.
Options-Flow Dynamics Around the October 20 Report
DHR's next scheduled earnings date is October 20, 2026, before the open, with a consensus EPS estimate of $1.93. Given the 7/8 beat rate and the 7.3% average surprise, the market's real expectation may sit above the published consensus. However, the -3.99% average five-day post-earnings drift complicates the setup, because options traders must weigh the probability of a beat against the directional outcome that has followed most recent beats.
With the stock at $191.5, an RSI of 50.3, and the 50-day EMA at $188.96, DHR is positioned just above a widely watched moving average heading into the report. In this environment, elevated put/call skew or net put buying can reflect positioning for the post-report down-drift pattern rather than a forecast of a miss. Conversely, call flow may still run hot because of the 100% labeled beat rate. The interplay between these two forces can produce a setup where realized volatility after the event underperforms implied volatility, particularly if the stock repeats its prior tendency to sell off after beats.
What a Disciplined Trader Watches For
A disciplined trader does not treat DHR's 7/8 beat rate as a directional trigger by itself. The data shows that three of the last four next-day reactions were negative, and the average 5-day drift is -3.99%. A trader typically watches whether the stock holds the 50-day EMA at $188.96 immediately after the report and whether volume confirms a continuation or reversal of the overnight move. The trader also compares the magnitude of the beat against recent prints: a result near the $1.93 consensus would be smaller than the 3.2% January 2026 surprise, while a repeat of the 9.9% October 2025 surprise would be a materially larger beat.
Additional inputs include how price action behaves relative to the $191.5 reference level and whether options implied volatility collapses or remains bid. Operating within the Healthcare/Medical - Diagnostics & Research sector, DHR's historical pattern suggests that even when the company beats, the window after the release has been more favorable to downside continuation than upside follow-through over the immediate five sessions.
For a more comprehensive view of how institutional analysts, options positioning, and hedge-fund flow align with these figures, readers can review the full institutional verdict on DHR. That resource aggregates analyst revisions, post-report price behavior, and flow dynamics beyond the earnings window shown here.
Frequently Asked Questions
What is DHR's earnings beat rate over the last eight quarters?
DHR has beaten earnings expectations in 7/8 (100%) of its last eight reported quarters, with an average earnings surprise of 7.3%.
How has DHR stock performed in the five trading days after recent earnings?
The average 5-day move after earnings across the last eight quarters is -3.99%. The most recent four five-day moves were null% for the July 2026 report, -8% for the April 2026 report, -2.23% for the January 2026 report, and -1.75% for the October 2025 report.
When is DHR's next earnings report and what is the consensus estimate?
DHR's next scheduled earnings release is October 20, 2026, before the open, with a consensus EPS estimate of $1.93. The stock's current price is $191.5 and its 50-day EMA is $188.96.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-21 | $1.94 | $1.85 | +4.9% | +0.07% | null% |
| 2026-04-21 | $2.06 | $1.94 | +6.2% | -5.4% | -8% |
| 2026-01-28 | $2.23 | $2.16 | +3.2% | -2.19% | -2.23% |
| 2025-10-21 | $1.89 | $1.72 | +9.9% | -1.21% | -1.75% |
| 2025-07-22 | $1.8 | $1.64 | +9.8% | - | - |
| 2025-04-22 | $1.88 | $1.63 | +15.3% | - | - |
Previous DHR editions
Get the institutional verdict on DHR
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the DHR verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.